Form 4 for RLYB Rallybio Corp
Accepted 2023-03-09 00:00:00 ET · period of report 2023-03-07 · accession 0001209191-23-017538 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-03-09 | 2023-03-07 | RLYB | PARMAR KUSH | Dir | S - Sale | $8.20 | -100.0K | 2.38M | -4% | -$820.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-07 | S | D | 100,000 | $8.20 | 2,378,969 | I By 5AM Ventures V, L.P. | — | — | (F1) These securities are held directly by 5AM Ventures V, L.P. ("Ventures V"). 5AM Partners V, LLC ("Partners V") is the sole general partner of Ventures V. Dr. Parmar is a managing member of Partners V and may be deemed to share voting and investment power over the securities held by Ventures V. Dr. Parmar disclaims beneficial ownership of the securities held by Ventures V except to the extent of his pecuniary interest therein. |